222 related articles for article (PubMed ID: 37698826)
21. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
22. The maturation of iPS cell-derived brain microvascular endothelial cells by inducible-SOX18 expression.
Zhang H; Yamaguchi T; Kawabata K
Fluids Barriers CNS; 2023 Feb; 20(1):10. PubMed ID: 36732767
[TBL] [Abstract][Full Text] [Related]
23. Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier.
Holst MR; de Wit NM; Ozgür B; Brachner A; Hyldig K; Appelt-Menzel A; Sleven H; Cader Z; de Vries HE; Neuhaus W; Jensen A; Brodin B; Nielsen MS
Fluids Barriers CNS; 2023 Nov; 20(1):82. PubMed ID: 37932749
[TBL] [Abstract][Full Text] [Related]
24. Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line.
Ozgür B; Puris E; Brachner A; Appelt-Menzel A; Oerter S; Balzer V; Holst MR; Christiansen RF; Hyldig K; Buckley ST; Kristensen M; Auriola S; Jensen A; Fricker G; Nielsen MS; Neuhaus W; Brodin B
Fluids Barriers CNS; 2023 Dec; 20(1):96. PubMed ID: 38115090
[TBL] [Abstract][Full Text] [Related]
25. Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport.
Molino Y; Jabès F; Lacassagne E; Gaudin N; Khrestchatisky M
J Vis Exp; 2014 Jun; (88):e51278. PubMed ID: 24998179
[TBL] [Abstract][Full Text] [Related]
26. Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.
Karaoglu Hanzatian D; Schwartz A; Gizatullin F; Erickson J; Deng K; Villanueva R; Stedman C; Harris C; Ghayur T; Goodearl A
MAbs; 2018 Jul; 10(5):765-777. PubMed ID: 29771629
[TBL] [Abstract][Full Text] [Related]
27. Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells.
Stebbins MJ; Lippmann ES; Faubion MG; Daneman R; Palecek SP; Shusta EV
Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 28960887
[TBL] [Abstract][Full Text] [Related]
28. Construction and Functional Evaluation of a Three-Dimensional Blood-Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells.
Kurosawa T; Sako D; Tega Y; Debori Y; Tomihara Y; Aoyama K; Kubo Y; Amano N; Deguchi Y
Pharm Res; 2022 Jul; 39(7):1535-1547. PubMed ID: 35411503
[TBL] [Abstract][Full Text] [Related]
29. Prediction of Drug Permeability Using
Ohshima M; Kamei S; Fushimi H; Mima S; Yamada T; Yamamoto T
Biores Open Access; 2019; 8(1):200-209. PubMed ID: 31737437
[TBL] [Abstract][Full Text] [Related]
30. Human iPSC-derived brain endothelial microvessels in a multi-well format enable permeability screens of anti-inflammatory drugs.
Fengler S; Kurkowsky B; Kaushalya SK; Roth W; Fava E; Denner P
Biomaterials; 2022 Jul; 286():121525. PubMed ID: 35599022
[TBL] [Abstract][Full Text] [Related]
31. Endosomal trafficking regulates receptor-mediated transcytosis of antibodies across the blood brain barrier.
Haqqani AS; Delaney CE; Brunette E; Baumann E; Farrington GK; Sisk W; Eldredge J; Ding W; Tremblay TL; Stanimirovic DB
J Cereb Blood Flow Metab; 2018 Apr; 38(4):727-740. PubMed ID: 29140158
[TBL] [Abstract][Full Text] [Related]
32. Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid transporter 1 (SLC7A5).
Goldeman C; Andersen M; Al-Robai A; Buchholtz T; Svane N; Ozgür B; Holst B; Shusta E; Hall VJ; Saaby L; Hyttel P; Brodin B
Eur J Pharm Sci; 2021 Jan; 156():105577. PubMed ID: 33011235
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human.
Zhang W; Liu QY; Haqqani AS; Leclerc S; Liu Z; Fauteux F; Baumann E; Delaney CE; Ly D; Star AT; Brunette E; Sodja C; Hewitt M; Sandhu JK; Stanimirovic DB
Fluids Barriers CNS; 2020 Jul; 17(1):47. PubMed ID: 32698806
[TBL] [Abstract][Full Text] [Related]
34. A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding.
Sade H; Baumgartner C; Hugenmatter A; Moessner E; Freskgård PO; Niewoehner J
PLoS One; 2014; 9(4):e96340. PubMed ID: 24788759
[TBL] [Abstract][Full Text] [Related]
35. Transcytosis of payloads that are non-covalently complexed to bispecific antibodies across the hCMEC/D3 blood-brain barrier model.
Schmid D; Buntz A; Hanh Phan TN; Mayer K; Hoffmann E; Thorey I; Niewöhner J; Vasters K; Sircar R; Mundigl O; Kontermann RE; Brinkmann U
Biol Chem; 2018 Jun; 399(7):711-721. PubMed ID: 29466231
[TBL] [Abstract][Full Text] [Related]
36. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
[TBL] [Abstract][Full Text] [Related]
37. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
38. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
Webster CI; Caram-Salas N; Haqqani AS; Thom G; Brown L; Rennie K; Yogi A; Costain W; Brunette E; Stanimirovic DB
FASEB J; 2016 May; 30(5):1927-40. PubMed ID: 26839377
[TBL] [Abstract][Full Text] [Related]
39. Advanced translational PBPK model for transferrin receptor-mediated drug delivery to the brain.
Sato S; Liu S; Goto A; Yoneyama T; Okita K; Yamamoto S; Hirabayashi H; Iwasaki S; Kusuhara H
J Control Release; 2023 May; 357():379-393. PubMed ID: 37031741
[TBL] [Abstract][Full Text] [Related]
40. Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle.
Sehlin D; Stocki P; Gustavsson T; Hultqvist G; Walsh FS; Rutkowski JL; Syvänen S
FASEB J; 2020 Oct; 34(10):13272-13283. PubMed ID: 32779267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
